Loading...

MRSN MERSANA THERAPEUTICS INC Delisting Actions 8-K Filing

MRSN

MRSN

MERSANA THERAPEUTICS INC

(MRSN)

2025 8-K

Show Summary

Summary

Loan Defaults (Secured, Uns...

Reverse Stock Split

New Product Launches

Financial Statements

Management Changes

Financial Results

Corporate Update

Corporate Update

Clinical Trial Update

Stock Exchange Agreement

Financial Results

Financial Results

Annual Meeting of Stockholders

Earnings Report

Sales Agreement

Financial Results Announcement

Disclosure and Business Upd...

Termination of Agreement

Financial Results Announcement

FDA Clinical Hold Lifted

Financial Results Announcement

Financial Results and Restr...

Clinical Hold Announcement

Amendment and Annual Meeting

Earnings Reports

Bylaws Amendments

Loan Agreement Amendment

Financial Results Announcement

Presentation and Clinical T...

Disclosure and Other Events

Financial Update

External Links:

On February 25, 2025, Mersana Therapeutics received a notice from Nasdaq for not meeting the minimum bid price of $1.00 per share for 30 consecutive days, giving them until August 25, 2025, to regain compliance or face potential delisting.

AI Assistant

MERSANA THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.